Impact of kynurenine 3-monooxygenase expression on outcome in patients with triple-negative breast cancer undergone primary treatments

被引：0
|
作者：
Wu, C-Y
Chu, P-Y
Wang, W-L
Liu, C-Y
Tseng, L-M
机构：
[1] Taipei Vet Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Taipei, Taiwan
[4] Show Chwan Mem Hosp, Changhua, Taiwan
[5] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P2-02-25
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-25
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The prognostic impact of age in patients with triple-negative breast cancer.
    Liedtke, C.
    Gluz, D.
    Kiesel, L.
    Hortobagyi, G. N.
    Pusztai, L.
    Gonzalez-Angulo, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Locoregional Recurrence in Patients with Triple-negative Breast Cancer: The Impact of Radiotherapy
    Dragun, A. E.
    Pan, J.
    Jain, D.
    Kruse, B.
    Rai, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S216 - S216
  • [23] The Impact of Radiotherapy in Patients with Triple-negative Breast Cancer following Mastectomy
    Chen, X.
    Yu, X.
    Guo, X.
    Chen, J.
    Shao, Z.
    Feng, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S235 - S235
  • [24] Expression patterns of claudins in patients with triple-negative breast cancer are associated with nodal metastasis and worse outcome
    Katayama, Ayaka
    Handa, Tadashi
    Komatsu, Kei
    Togo, Maria
    Horiguchi, Jun
    Nishiyama, Masahiko
    Oyama, Tetsunari
    PATHOLOGY INTERNATIONAL, 2017, 67 (08) : 404 - 413
  • [25] Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
    Soley Bayraktar
    Angelica M. Gutierrez-Barrera
    Diane Liu
    Tunc Tasbas
    Ugur Akar
    Jennifer K. Litton
    E. Lin
    Constance T. Albarracin
    Funda Meric-Bernstam
    Ana M. Gonzalez-Angulo
    Gabriel N. Hortobagyi
    Banu K. Arun
    Breast Cancer Research and Treatment, 2011, 130
  • [26] Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations
    Bayraktar, Soley
    Gutierrez-Barrera, Angelica M.
    Liu, Diane
    Tasbas, Tunc
    Akar, Ugur
    Litton, Jennifer K.
    Lin, E.
    Albarracin, Constance T.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Arun, Banu K.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (01) : 145 - 153
  • [27] Significance of the vimentin expression in triple-negative breast cancer
    Yamashita, Nami
    Tokunaga, Eriko
    Kitao, Hiroyuki
    Tanaka, Kimihiro
    Taketani, Kenji
    Saeki, Hiroshi
    Aishima, Shinichi
    Oki, Eiji
    Morita, Masaru
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Expression of Dicer and Drosha in triple-negative breast cancer
    Passon, Nadia
    Gerometta, Anna
    Puppin, Cinzia
    Lavarone, Elisa
    Puglisi, Fabio
    Tell, Gianluca
    Di Loreto, Carla
    Damante, Giuseppe
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (04) : 320 - 326
  • [29] Impact of Triple-Negative Breast Cancer Phenotype on Prognosis in Patients with Stage I Breast Cancer
    Kim, Jeong Eun
    Ahn, Heui June
    Ahn, Jin-Hee
    Yoon, Dok Hyun
    Kim, Sung-Bae
    Jung, Kyung Hae
    Gong, Gyung-Yub
    Kim, Mi-Jung
    Son, Byung Ho
    Ahn, Sei Hyun
    JOURNAL OF BREAST CANCER, 2012, 15 (02) : 197 - 202
  • [30] Androgen receptor expression in triple-negative breast cancer
    Glavynskyi, I.
    Dyatel, M.
    Zakhartseva, L.
    Guz, O.
    Zakhartsev, I.
    VIRCHOWS ARCHIV, 2017, 471 : S294 - S294
12345